人工智能对息肉切除后结肠镜监测的影响:随机试验的汇总分析
该汇总分析纳入9项随机对照试验共5796例患者,比较人工智能辅助结肠镜与非人工智能结肠镜对息肉切除后监测推荐的影响。按美国指南,人工智能组需强化监测(3年间隔)的比例从8.4%升至11.3%(风险比1.35);按欧洲指南,该比例从6.1%升至7.4%(风险比1.22)。作者认为人工智能可能改善癌症预防,但显著增加患者负担和医疗成本。
要点
- 人工智能辅助结肠镜使美国指南下需3年监测的患者比例绝对增加2.9%(风险比1.35)。
- 欧洲指南下该比例绝对增加1.3%(风险比1.22)。
- 人工智能提高息肉检出率的同时增加了监测负担和医疗成本。
核心结论
- 结肠镜中使用人工智能使需强化结肠镜监测的患者比例在美国增加约35%、欧洲增加约20%(绝对增加分别为2.9%和1.3%)。
- 作者认为这可能有助于改善癌症预防,但显著增加患者负担和医疗成本。
研究设计与样本
- 对9项比较人工智能辅助结肠镜与非人工智能结肠镜的随机对照试验进行汇总分析(中国5项、意大利2项、日本1项、美国1项)。
- 共纳入5796例患者(51%男性,平均53岁),其中2894例接受人工智能辅助结肠镜,2902例接受非人工智能结肠镜。
- 主要结局为被推荐接受强化监测(即3年间隔)的患者比例,分别按美国和欧洲推荐分析监测间隔。
- 采用Mantel-Haenszel方法计算相对风险来估计比例。
主要发现
- 按美国指南,非人工智能组推荐强化监测比例为8.4%(95% CI,7.4%-9.5%),人工智能组为11.3%(95% CI,10.2%-12.6%);绝对差异2.9%(95% CI,1.4%-4.4%),风险比1.35(95% CI,1.16-1.57)。
- 按欧洲指南,非人工智能组比例为6.1%(95% CI,5.3%-7.0%),人工智能组为7.4%(95% CI,6.5%-8.4%);绝对差异1.3%(95% CI,0.01%-2.6%),风险比1.22(95% CI,1.01-1.47)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Artificial intelligence (AI) tools aimed at improving polyp detection have been shown to increase the adenoma detection rate during colonoscopy. However, it is unknown how increased polyp detection rates by AI affect the burden of patient surveillance after polyp removal. METHODS: We conducted a pooled analysis of 9 randomized controlled trials (5 in China, 2 in Italy, 1 in Japan, and 1 in the United States) comparing colonoscopy with or without AI detection aids. The primary outcome was the proportion of patients recommended to undergo intensive surveillance (ie, 3-year interval). We analyzed intervals for AI and non-AI colonoscopies for the U.S. and European recommendations separately. We estimated proportions by calculating relative risks using the Mantel-Haenszel method. RESULTS: A total of 5796 patients (51% male, mean 53 years of age) were included; 2894 underwent AI-assisted colonoscopy and 2902 non-AI colonoscopy. When following U.S. guidelines, the proportion of patients recommended intensive surveillance increased from 8.4% (95% CI, 7.4%-9.5%) in the non-AI group to 11.3% (95% CI, 10.2%-12.6%) in the AI group (absolute difference, 2.9% [95% CI, 1.4%-4.4%]; risk ratio, 1.35 [95% CI, 1.16-1.57]). When following European guidelines, it increased from 6.1% (95% CI, 5.3%-7.0%) to 7.4% (95% CI, 6.5%-8.4%) (absolute difference, 1.3% [95% CI, 0.01%-2.6%]; risk ratio, 1.22 [95% CI, 1.01-1.47]). CONCLUSIONS: The use of AI during colonoscopy increased the proportion of patients requiring intensive colonoscopy surveillance by approximately 35% in the United States and 20% in Europe (absolute increases of 2.9% and 1.3%, respectively). While this may contribute to improved cancer prevention, it significantly adds patient burden and healthcare costs.
引用
- Mori Y, Wang P, Løberg M, et al. Impact of Artificial Intelligence on Colonoscopy Surveillance After Polyp Removal: A Pooled Analysis of Randomized Trials. Clin Gastroenterol Hepatol. 2022. PMID: 36038128. doi:10.1016/j.cgh.2022.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。